Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.12, 2005-12, pp. : 1561-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

By Kiaris Hippokratis   Koutsilieris Michael   Kalofoutis Anastasios   Schally Andrew V  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite

Endocrine and Antineoplastic Actions of Growth Hormone-Releasing Hormone Antagonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 314-321

Bentham Science Publishers

Access to resources Recommend Favorite

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

By Msaouel Pavlos   Diamanti Evanthia   Tzanela Marinela   Koutsilieris Michael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 285-299

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonists

By Herbst K.L.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 660-666

Elsevier

Access to resources Recommend Favorite

Growth Hormone Secretagogues: Focus on the Growth Hormone-Releasing Peptides

By Locatelli V.   Torsello A.  

Pharmacological Research, Vol. 36, Iss. 6, 1997-12 ,pp. : 415-423

Academic Press

Access to resources Recommend Favorite